RWE appears in 70% of FDA drug submissions. But manual analysis can't keep pace with growing data volumes. ML can, if your environment is built for it. Read the full article in @MedCityNews
:
Machine Learning Accelerates FDA Drug Submission Analysis at Scale
By
–